SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Genaera Corp
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: DewDiligence_on_SI who wrote (59)9/13/2005 8:35:37 PM
From: Dave Mordis  Read Replies (1) of 96
 
Dew, responding to this post and your yahoo posts. Agree that they will need a partner to manufacture the drug and to market the drug. It would be difficult if not impossible for them to get drug reps into all the retina specialists to promote the drug. Although if Squalamine is clearly more effective than the other modalities you might see Retina specialists hunting around to get the drug. Can't emphasize enough how the typical retina specialist would prefer to have an RN administer a med IV than give the shot themself. I've administered them and they're not fun from a patient's or MD's perspective. Plus the retina guy can make more money if an Rx modality can be delegated o someone else. Most Retina guys get home 1-2 hours later than their general Ophthalmology colleagues so they're not looking for any extra work than what they already have.
I have discussed Squalamine with a friend of mine who's a retina specialist last winter when I was out visiting in Scottsdale. He hadn't heard of it and expressed the same concerns you had about systemic side effects with systemic administration. Haven't been able to get him to respond however to any of the data I've emailed him. He says he's too busy working 12 hours a day to read email when he gets home.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News